Optimise first-line therapy for stable angina, NICE advises
First-line drug therapy should be optimised before patients are offered revascularisation procedures for the management of stable angina, according to a new clinical guideline published by the National Institute for Health and Clinical Excellence. NICE advises that first-line treatment should include one or two antianginal medicines plus a short-acting nitrate and medicines for the secondary prevention of cardiovascular disease. Revascularisation is reserved for patients in whom drug treatment does not control symptoms.
Citation: Clinical Pharmacist URI: 11083348
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.